1. De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial. Issue 2 (23rd January 2014) Authors: Asrani, S. K.; Wiesner, R. H.; Trotter, J. F.; Klintmalm, G.; Katz, E.; Maller, E.; Roberts, J.; Kneteman, N.; Teperman, L.; Fung, J. J.; Millis, J. M. Journal: American journal of transplantation Issue: Volume 14:Issue 2(2014:Feb.) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0140 Tofacitinib (CP-690, 550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. (23rd January 2014) Authors: Lee, E.B.; Curtis, J.R.; Riese, R.; Connell, C.; Chew, R.; Boy, M.; Maller, E.; Su, C.; Wang, L.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗